Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

EADV spring symposium: Bioalliance Pharma presents Sitavig study results

BioAlliance Pharma SA, a Company dedicated to the development of orphan oncology products and supportive care products, has presented the results of the pharmacokinetic and pharmacodynamic study on Sitavig at the 10th EADV spring symposium (European Academy of Dermatology and Venereology) in Cracow (Poland) on May 24, 2013.

28 May 2013

Neuroscientists identify key circuit elements that contribute to everyday decision in ACC

You are sitting on your couch flipping through TV channels trying to decide whether to stay put or get up for a snack. Such everyday decisions about whether to "stay" or to "go" are supported by a brain region called the anterior cingulate cortex (ACC), which is part of the prefrontal cortex.

27 May 2013

Children who miss well-child visits have twice the risk of hospitalization

Young children who missed more than half of recommended well-child visits had up to twice the risk of hospitalization compared to children who attended most of their visits, according to a study published today in the American Journal of Managed Care. The study included more than 20,000 children enrolled at Group Health Cooperative.

27 May 2013

Mortality rates are highest in heart failure patients admitted in January, on Friday, and overnight

Mortality and length of stay are highest in heart failure patients admitted in January, on Friday, and overnight, according to research presented today at the Heart Failure Congress 2013. The analysis of nearly 1 million heart failure admissions over 14 years was presented by Dr David P. Kao (Denver, Colorado).

27 May 2013

VINARES project aims to strengthen evidence-based control of antibiotic use in Vietnam

The increasingly widespread resistance to antibiotics is a global threat. One of the most vulnerable countries is Vietnam, with 90 million inhabitants. In an attempt to change this development, the VINARES project was started in the autumn of 2012 led by researchers from Sweden, UK and Vietnam.

27 May 2013

Sinovac Beijing receives GMP certificate for its proprietary vaccines

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced that Sinovac Beijing, the main operating subsidiary company of Sinovac, obtained the Certificate of Good Manufacturing Practices for Pharmaceutical Products (GMP Certificate) from the China State and Food Administration (CFDA) for its proprietary vaccines, its Haidian district bulk production plants, and its Changping filing and packaging facility.

24 May 2013

New, improved drugs can boost body's natural flu killer system

A known difficulty in fighting influenza (flu) is the ability of the flu viruses to mutate and thus evade various medications that were previously found to be effective. Researchers at the Hebrew University of Jerusalem have shown recently that another, more promising, approach is to focus on improving drugs that boost the body's natural flu killer system.

24 May 2013

Findings highlight importance of IL-21 in the development of antiviral vaccines

Scientists at Emory Vaccine Center have shown that an immune regulatory molecule called IL-21 is needed for long-lasting antibody responses in mice against viral infections.

24 May 2013

Viewpoints: Sen. Alexander sees reflections of Oliver North in Sebelius' quest to raise funds; vaccine scare's legacy

Major news outlets in recent days have reported that U.S. Department of Health and Human Services Secretary Kathleen Sebelius is raising money from the private sector -- including from health care executives -- for use by a private entity that is helping to implement ObamaCare. ... Is Ms. Sebelius raising funds for a private entity and then coordinating with that entity to do something Congress has refused to authorize, or for which it has refused to appropriate funds?

24 May 2013

CCSC, HHS honor hospitals, health care facilities for preventing HAIs

The Critical Care Societies Collaborative, in partnership with the U.S. Department of Health and Human Services, announces recipients in the 2013 National Awards Program to Recognize Achievements in Eliminating Health Care-Associated Infections.

24 May 2013

Wisconsin scientists synthesize potent compounds to curb bacteria that cause staph infections

In an age when microbial pathogens are growing increasingly resistant to the conventional antibiotics used to tamp down infection, a team of Wisconsin scientists has synthesized a potent new class of compounds capable of curbing the bacteria that cause staph infections.

24 May 2013

FDA gives Priority Review to Celgene's ABRAXANE sNDA for advanced pancreatic cancer

Celgene International Sàrl, a subsidiary of Celgene Corporation today announced that the U.S. Food and Drug Administration has assigned a Priority Review designation to the supplemental New Drug Application for the use of ABRAXANE (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) in combination with gemcitabine for the first-line treatment of patients with advanced pancreatic cancer.

23 May 2013

Physicists develop novel technique that can detect molecular variants

Harvard physicists have developed a novel technique that can detect molecular variants in chemical mixtures - greatly simplifying a process that is one of the most important, though time-consuming, processes in analytical chemistry.

23 May 2013

Prosonix commences Phase 2 clinical study of PSX1002 for treatment of moderate to severe COPD

Prosonix, an innovative speciality pharmaceutical company developing a portfolio of inhaled Respiratory Medicines by Design, has initiated a Phase 2 clinical study with PSX1002 that will assess its effect on lung function and the safety of a range of doses in patients with moderate to severe chronic obstructive pulmonary disease.

23 May 2013

Physicists demonstrate effect of cold atmospheric plasma, chemo therapy on brain tumour cells

For the first time, physicists from the Max Planck Institute for Extraterrestrial Physics (MPE), biologists and physicians demonstrated the synergistic effect of cold atmospheric plasma - a partly ionized gas - and chemo therapy on aggressive brain tumour cells.

23 May 2013

Researchers find that over 40% of patients treated for COPD did not actually have the disease

More than 40 percent of patients being treated for COPD at a federally funded clinic did not have the disease, researchers found after evaluating the patients with spirometry, the diagnostic "gold standard" for chronic obstructive pulmonary disease.

23 May 2013

Scientists make important step forward in the quest to develop universal influenza vaccine

A new approach for immunizing against influenza elicited a more potent immune response and broader protection than the currently licensed seasonal influenza vaccines when tested in mice and ferrets.

23 May 2013

MUC5B gene variation improves survival in patients with idiopathic pulmonary fibrosis

Variation in the gene MUC5B among patients with idiopathic pulmonary fibrosis was associated with improved survival, according to a study published online by JAMA. The study is being released early online to coincide with its presentation at the American Thoracic Society international conference.

22 May 2013

iBio announces production of vaccine candidate for new H7N9 influenza virus

iBio, Inc. today announced the production of a vaccine candidate for the newly emerged H7N9 influenza virus by an independent third party laboratory using the iBioLaunch platform.

22 May 2013

Genetic risk factor for pulmonary fibrosis can be used to identify individuals at risk for lung disease

A paper recently published in the New England Journal of Medicine and co-written by physicians and scientists at the University of Colorado School of Medicine finds that an important genetic risk factor for pulmonary fibrosis can be used to identify individuals at risk for this deadly lung disease.

22 May 2013

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

EADV spring symposium: Bioalliance Pharma presents Sitavig study results

Neuroscientists identify key circuit elements that contribute to everyday decision in ACC

Children who miss well-child visits have twice the risk of hospitalization

Mortality rates are highest in heart failure patients admitted in January, on Friday, and overnight

VINARES project aims to strengthen evidence-based control of antibiotic use in Vietnam

Sinovac Beijing receives GMP certificate for its proprietary vaccines

New, improved drugs can boost body's natural flu killer system

Findings highlight importance of IL-21 in the development of antiviral vaccines

Viewpoints: Sen. Alexander sees reflections of Oliver North in Sebelius' quest to raise funds; vaccine scare's legacy

CCSC, HHS honor hospitals, health care facilities for preventing HAIs

Wisconsin scientists synthesize potent compounds to curb bacteria that cause staph infections

FDA gives Priority Review to Celgene's ABRAXANE sNDA for advanced pancreatic cancer

Physicists develop novel technique that can detect molecular variants

Prosonix commences Phase 2 clinical study of PSX1002 for treatment of moderate to severe COPD

Physicists demonstrate effect of cold atmospheric plasma, chemo therapy on brain tumour cells

Researchers find that over 40% of patients treated for COPD did not actually have the disease

Scientists make important step forward in the quest to develop universal influenza vaccine

MUC5B gene variation improves survival in patients with idiopathic pulmonary fibrosis

iBio announces production of vaccine candidate for new H7N9 influenza virus

Genetic risk factor for pulmonary fibrosis can be used to identify individuals at risk for lung disease

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Newsletters you may be interested in